You do realize that the only published data to date are a few preclinical reports and the 148 week phase 2 AD trial.. I assume the Rett data would be of interest to a pediatric dementia trial -- all the US Rett and the Avatar data we have seen over the last 2 years is unpublished. It's doubtful they saw anything unavailable of material importance.